TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

126 hedge funds and large institutions have $559M invested in Tvardi Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

4% less call options, than puts

Call options by funds: $20.9M | Put options by funds: $21.7M

7% less funds holding

Funds holding: 135 → 126 (-9)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

Holders
126
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$20.9M
Puts
$21.7M
Net Calls
Net Calls Change

Top Buyers

1
+$20.6M
2
+$20.5M
3
+$20.5M
4
CWG
C WorldWide Group
Denmark
+$12M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.73M

Top Sellers

1
-$6.45M
2
-$5.96M
3
-$3.92M
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$2.39M
5
C
Chescapmanager
Maryland
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
126
$723
127
–
128
–
129
–
130
–
131
–
132
–
133
–
134
–
135
–
136
–
137
–
138
–
139
–
140
–
141
–
142
–
143
–
144
–
145
–
146
–
147
–
2 3 4 5
6